Johnson & Johnson

Martin Makary FDA Senate HELP confirmation

Biotech

FDA reveals 2nd round of 'national priority' voucher winners

The program is designed to cut the agency's typical 10- to 12-month review timeline down to just one or two months.

Darren Incorvaia Nov 6, 2025 3:12pm

Halloween deal shake hands zombie

Nanobiotix finds new way to source cash from J&J-partnered drug

Oct 31, 2025 6:05am

J&J MedTech, Verily pen Nvidia deals

Oct 29, 2025 8:45am

JNJ

J&J reveals plan to spin off its $9B orthopedics business

Oct 14, 2025 11:30am

An open book with pages turning on a wooden table set

J&J eyes takeover of immunology partner Protagonist: WSJ

Oct 10, 2025 2:30pm

AI drug discovery pill machine learning drug targets data

BMS, Takeda join peers in push to improve AI by pooling data

Oct 1, 2025 10:34am